Global Transdermal Patch Market Analysis and Forecast 2024-2030
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
According to APO Research, The global Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
This report presents an overview of global market for Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transdermal Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grьnenthal and IBSA Group, etc.
Transdermal Patch segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Transdermal Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Patch sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
This report presents an overview of global market for Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transdermal Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grьnenthal and IBSA Group, etc.
Transdermal Patch segment by Company
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Novartis
- UCB Pharma
- Mylan
- Teva Pharmaceutical
- Nitto Denko
- Grьnenthal
- IBSA Group
- GSK
- Luye Pharma Group
- Pfizer
- Chattem
- Dr Reddy’s Laboratories
- Bayer
- Mundipharma
- Endo International
- Beijing Tide Pharmaceutical
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Lidocaine Patch
- Diclofenac Patch
- Nicotine Transdermal Patch
- Others
- Rx Channel
- OTC Channel
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Transdermal Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Patch sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Transdermal Patch Market by Type
1.2.1 Global Transdermal Patch Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Patch Market by Application
1.3.1 Global Transdermal Patch Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 TRANSDERMAL PATCH MARKET DYNAMICS
2.1 Transdermal Patch Industry Trends
2.2 Transdermal Patch Industry Drivers
2.3 Transdermal Patch Industry Opportunities and Challenges
2.4 Transdermal Patch Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Transdermal Patch Revenue Estimates and Forecasts (2019-2030)
3.2 Global Transdermal Patch Revenue by Region
3.2.1 Global Transdermal Patch Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Transdermal Patch Revenue by Region (2019-2024)
3.2.3 Global Transdermal Patch Revenue by Region (2025-2030)
3.2.4 Global Transdermal Patch Revenue Market Share by Region (2019-2030)
3.3 Global Transdermal Patch Sales Estimates and Forecasts 2019-2030
3.4 Global Transdermal Patch Sales by Region
3.4.1 Global Transdermal Patch Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Transdermal Patch Sales by Region (2019-2024)
3.4.3 Global Transdermal Patch Sales by Region (2025-2030)
3.4.4 Global Transdermal Patch Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Transdermal Patch Revenue by Manufacturers
4.1.1 Global Transdermal Patch Revenue by Manufacturers (2019-2024)
4.1.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Transdermal Patch Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Transdermal Patch Sales by Manufacturers
4.2.1 Global Transdermal Patch Sales by Manufacturers (2019-2024)
4.2.2 Global Transdermal Patch Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Transdermal Patch Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Transdermal Patch Sales Price by Manufacturers (2019-2024)
4.4 Global Transdermal Patch Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Transdermal Patch Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Transdermal Patch Manufacturers, Product Type & Application
4.7 Global Transdermal Patch Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Transdermal Patch Market CR5 and HHI
4.8.2 2023 Transdermal Patch Tier 1, Tier 2, and Tier
5 TRANSDERMAL PATCH MARKET BY TYPE
5.1 Global Transdermal Patch Revenue by Type
5.1.1 Global Transdermal Patch Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Transdermal Patch Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Transdermal Patch Revenue Market Share by Type (2019-2030)
5.2 Global Transdermal Patch Sales by Type
5.2.1 Global Transdermal Patch Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Transdermal Patch Sales by Type (2019-2030) & (M Pcs)
5.2.3 Global Transdermal Patch Sales Market Share by Type (2019-2030)
5.3 Global Transdermal Patch Price by Type
6 TRANSDERMAL PATCH MARKET BY APPLICATION
6.1 Global Transdermal Patch Revenue by Application
6.1.1 Global Transdermal Patch Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Transdermal Patch Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Transdermal Patch Revenue Market Share by Application (2019-2030)
6.2 Global Transdermal Patch Sales by Application
6.2.1 Global Transdermal Patch Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Transdermal Patch Sales by Application (2019-2030) & (M Pcs)
6.2.3 Global Transdermal Patch Sales Market Share by Application (2019-2030)
6.3 Global Transdermal Patch Price by Application
7 COMPANY PROFILES
7.1 Hisamitsu Pharmaceutical
7.1.1 Hisamitsu Pharmaceutical Comapny Information
7.1.2 Hisamitsu Pharmaceutical Business Overview
7.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
7.1.5 Hisamitsu Pharmaceutical Recent Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Comapny Information
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
7.2.5 Johnson & Johnson Recent Developments
7.3 Novartis
7.3.1 Novartis Comapny Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Novartis Transdermal Patch Product Portfolio
7.3.5 Novartis Recent Developments
7.4 UCB Pharma
7.4.1 UCB Pharma Comapny Information
7.4.2 UCB Pharma Business Overview
7.4.3 UCB Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 UCB Pharma Transdermal Patch Product Portfolio
7.4.5 UCB Pharma Recent Developments
7.5 Mylan
7.5.1 Mylan Comapny Information
7.5.2 Mylan Business Overview
7.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Mylan Transdermal Patch Product Portfolio
7.5.5 Mylan Recent Developments
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Comapny Information
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
7.6.5 Teva Pharmaceutical Recent Developments
7.7 Nitto Denko
7.7.1 Nitto Denko Comapny Information
7.7.2 Nitto Denko Business Overview
7.7.3 Nitto Denko Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Nitto Denko Transdermal Patch Product Portfolio
7.7.5 Nitto Denko Recent Developments
7.8 Grьnenthal
7.8.1 Grьnenthal Comapny Information
7.8.2 Grьnenthal Business Overview
7.8.3 Grьnenthal Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Grьnenthal Transdermal Patch Product Portfolio
7.8.5 Grьnenthal Recent Developments
7.9 IBSA Group
7.9.1 IBSA Group Comapny Information
7.9.2 IBSA Group Business Overview
7.9.3 IBSA Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 IBSA Group Transdermal Patch Product Portfolio
7.9.5 IBSA Group Recent Developments
7.10 GSK
7.10.1 GSK Comapny Information
7.10.2 GSK Business Overview
7.10.3 GSK Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 GSK Transdermal Patch Product Portfolio
7.10.5 GSK Recent Developments
7.11 Luye Pharma Group
7.11.1 Luye Pharma Group Comapny Information
7.11.2 Luye Pharma Group Business Overview
7.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
7.11.5 Luye Pharma Group Recent Developments
7.12 Pfizer
7.12.1 Pfizer Comapny Information
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Pfizer Transdermal Patch Product Portfolio
7.12.5 Pfizer Recent Developments
7.13 Chattem
7.13.1 Chattem Comapny Information
7.13.2 Chattem Business Overview
7.13.3 Chattem Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Chattem Transdermal Patch Product Portfolio
7.13.5 Chattem Recent Developments
7.14 Dr Reddy’s Laboratories
7.14.1 Dr Reddy’s Laboratories Comapny Information
7.14.2 Dr Reddy’s Laboratories Business Overview
7.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
7.14.5 Dr Reddy’s Laboratories Recent Developments
7.15 Bayer
7.15.1 Bayer Comapny Information
7.15.2 Bayer Business Overview
7.15.3 Bayer Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Bayer Transdermal Patch Product Portfolio
7.15.5 Bayer Recent Developments
7.16 Mundipharma
7.16.1 Mundipharma Comapny Information
7.16.2 Mundipharma Business Overview
7.16.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Mundipharma Transdermal Patch Product Portfolio
7.16.5 Mundipharma Recent Developments
7.17 Endo International
7.17.1 Endo International Comapny Information
7.17.2 Endo International Business Overview
7.17.3 Endo International Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Endo International Transdermal Patch Product Portfolio
7.17.5 Endo International Recent Developments
7.18 Beijing Tide Pharmaceutical
7.18.1 Beijing Tide Pharmaceutical Comapny Information
7.18.2 Beijing Tide Pharmaceutical Business Overview
7.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
7.18.5 Beijing Tide Pharmaceutical Recent Developments
8 NORTH AMERICA
8.1 North America Transdermal Patch Market Size by Type
8.1.1 North America Transdermal Patch Revenue by Type (2019-2030)
8.1.2 North America Transdermal Patch Sales by Type (2019-2030)
8.1.3 North America Transdermal Patch Price by Type (2019-2030)
8.2 North America Transdermal Patch Market Size by Application
8.2.1 North America Transdermal Patch Revenue by Application (2019-2030)
8.2.2 North America Transdermal Patch Sales by Application (2019-2030)
8.2.3 North America Transdermal Patch Price by Application (2019-2030)
8.3 North America Transdermal Patch Market Size by Country
8.3.1 North America Transdermal Patch Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Transdermal Patch Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Transdermal Patch Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Transdermal Patch Market Size by Type
9.1.1 Europe Transdermal Patch Revenue by Type (2019-2030)
9.1.2 Europe Transdermal Patch Sales by Type (2019-2030)
9.1.3 Europe Transdermal Patch Price by Type (2019-2030)
9.2 Europe Transdermal Patch Market Size by Application
9.2.1 Europe Transdermal Patch Revenue by Application (2019-2030)
9.2.2 Europe Transdermal Patch Sales by Application (2019-2030)
9.2.3 Europe Transdermal Patch Price by Application (2019-2030)
9.3 Europe Transdermal Patch Market Size by Country
9.3.1 Europe Transdermal Patch Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Transdermal Patch Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Transdermal Patch Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Transdermal Patch Market Size by Type
10.1.1 China Transdermal Patch Revenue by Type (2019-2030)
10.1.2 China Transdermal Patch Sales by Type (2019-2030)
10.1.3 China Transdermal Patch Price by Type (2019-2030)
10.2 China Transdermal Patch Market Size by Application
10.2.1 China Transdermal Patch Revenue by Application (2019-2030)
10.2.2 China Transdermal Patch Sales by Application (2019-2030)
10.2.3 China Transdermal Patch Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Transdermal Patch Market Size by Type
11.1.1 Asia Transdermal Patch Revenue by Type (2019-2030)
11.1.2 Asia Transdermal Patch Sales by Type (2019-2030)
11.1.3 Asia Transdermal Patch Price by Type (2019-2030)
11.2 Asia Transdermal Patch Market Size by Application
11.2.1 Asia Transdermal Patch Revenue by Application (2019-2030)
11.2.2 Asia Transdermal Patch Sales by Application (2019-2030)
11.2.3 Asia Transdermal Patch Price by Application (2019-2030)
11.3 Asia Transdermal Patch Market Size by Country
11.3.1 Asia Transdermal Patch Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Transdermal Patch Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Transdermal Patch Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Transdermal Patch Market Size by Type
12.1.1 MEALA Transdermal Patch Revenue by Type (2019-2030)
12.1.2 MEALA Transdermal Patch Sales by Type (2019-2030)
12.1.3 MEALA Transdermal Patch Price by Type (2019-2030)
12.2 MEALA Transdermal Patch Market Size by Application
12.2.1 MEALA Transdermal Patch Revenue by Application (2019-2030)
12.2.2 MEALA Transdermal Patch Sales by Application (2019-2030)
12.2.3 MEALA Transdermal Patch Price by Application (2019-2030)
12.3 MEALA Transdermal Patch Market Size by Country
12.3.1 MEALA Transdermal Patch Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Transdermal Patch Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Transdermal Patch Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Transdermal Patch Value Chain Analysis
13.1.1 Transdermal Patch Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Transdermal Patch Production Mode & Process
13.2 Transdermal Patch Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Transdermal Patch Distributors
13.2.3 Transdermal Patch Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Transdermal Patch Market by Type
1.2.1 Global Transdermal Patch Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Patch Market by Application
1.3.1 Global Transdermal Patch Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 TRANSDERMAL PATCH MARKET DYNAMICS
2.1 Transdermal Patch Industry Trends
2.2 Transdermal Patch Industry Drivers
2.3 Transdermal Patch Industry Opportunities and Challenges
2.4 Transdermal Patch Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Transdermal Patch Revenue Estimates and Forecasts (2019-2030)
3.2 Global Transdermal Patch Revenue by Region
3.2.1 Global Transdermal Patch Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Transdermal Patch Revenue by Region (2019-2024)
3.2.3 Global Transdermal Patch Revenue by Region (2025-2030)
3.2.4 Global Transdermal Patch Revenue Market Share by Region (2019-2030)
3.3 Global Transdermal Patch Sales Estimates and Forecasts 2019-2030
3.4 Global Transdermal Patch Sales by Region
3.4.1 Global Transdermal Patch Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Transdermal Patch Sales by Region (2019-2024)
3.4.3 Global Transdermal Patch Sales by Region (2025-2030)
3.4.4 Global Transdermal Patch Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Transdermal Patch Revenue by Manufacturers
4.1.1 Global Transdermal Patch Revenue by Manufacturers (2019-2024)
4.1.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Transdermal Patch Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Transdermal Patch Sales by Manufacturers
4.2.1 Global Transdermal Patch Sales by Manufacturers (2019-2024)
4.2.2 Global Transdermal Patch Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Transdermal Patch Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Transdermal Patch Sales Price by Manufacturers (2019-2024)
4.4 Global Transdermal Patch Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Transdermal Patch Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Transdermal Patch Manufacturers, Product Type & Application
4.7 Global Transdermal Patch Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Transdermal Patch Market CR5 and HHI
4.8.2 2023 Transdermal Patch Tier 1, Tier 2, and Tier
5 TRANSDERMAL PATCH MARKET BY TYPE
5.1 Global Transdermal Patch Revenue by Type
5.1.1 Global Transdermal Patch Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Transdermal Patch Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Transdermal Patch Revenue Market Share by Type (2019-2030)
5.2 Global Transdermal Patch Sales by Type
5.2.1 Global Transdermal Patch Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Transdermal Patch Sales by Type (2019-2030) & (M Pcs)
5.2.3 Global Transdermal Patch Sales Market Share by Type (2019-2030)
5.3 Global Transdermal Patch Price by Type
6 TRANSDERMAL PATCH MARKET BY APPLICATION
6.1 Global Transdermal Patch Revenue by Application
6.1.1 Global Transdermal Patch Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Transdermal Patch Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Transdermal Patch Revenue Market Share by Application (2019-2030)
6.2 Global Transdermal Patch Sales by Application
6.2.1 Global Transdermal Patch Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Transdermal Patch Sales by Application (2019-2030) & (M Pcs)
6.2.3 Global Transdermal Patch Sales Market Share by Application (2019-2030)
6.3 Global Transdermal Patch Price by Application
7 COMPANY PROFILES
7.1 Hisamitsu Pharmaceutical
7.1.1 Hisamitsu Pharmaceutical Comapny Information
7.1.2 Hisamitsu Pharmaceutical Business Overview
7.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
7.1.5 Hisamitsu Pharmaceutical Recent Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Comapny Information
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
7.2.5 Johnson & Johnson Recent Developments
7.3 Novartis
7.3.1 Novartis Comapny Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Novartis Transdermal Patch Product Portfolio
7.3.5 Novartis Recent Developments
7.4 UCB Pharma
7.4.1 UCB Pharma Comapny Information
7.4.2 UCB Pharma Business Overview
7.4.3 UCB Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 UCB Pharma Transdermal Patch Product Portfolio
7.4.5 UCB Pharma Recent Developments
7.5 Mylan
7.5.1 Mylan Comapny Information
7.5.2 Mylan Business Overview
7.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Mylan Transdermal Patch Product Portfolio
7.5.5 Mylan Recent Developments
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Comapny Information
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
7.6.5 Teva Pharmaceutical Recent Developments
7.7 Nitto Denko
7.7.1 Nitto Denko Comapny Information
7.7.2 Nitto Denko Business Overview
7.7.3 Nitto Denko Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Nitto Denko Transdermal Patch Product Portfolio
7.7.5 Nitto Denko Recent Developments
7.8 Grьnenthal
7.8.1 Grьnenthal Comapny Information
7.8.2 Grьnenthal Business Overview
7.8.3 Grьnenthal Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Grьnenthal Transdermal Patch Product Portfolio
7.8.5 Grьnenthal Recent Developments
7.9 IBSA Group
7.9.1 IBSA Group Comapny Information
7.9.2 IBSA Group Business Overview
7.9.3 IBSA Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 IBSA Group Transdermal Patch Product Portfolio
7.9.5 IBSA Group Recent Developments
7.10 GSK
7.10.1 GSK Comapny Information
7.10.2 GSK Business Overview
7.10.3 GSK Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 GSK Transdermal Patch Product Portfolio
7.10.5 GSK Recent Developments
7.11 Luye Pharma Group
7.11.1 Luye Pharma Group Comapny Information
7.11.2 Luye Pharma Group Business Overview
7.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
7.11.5 Luye Pharma Group Recent Developments
7.12 Pfizer
7.12.1 Pfizer Comapny Information
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Pfizer Transdermal Patch Product Portfolio
7.12.5 Pfizer Recent Developments
7.13 Chattem
7.13.1 Chattem Comapny Information
7.13.2 Chattem Business Overview
7.13.3 Chattem Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Chattem Transdermal Patch Product Portfolio
7.13.5 Chattem Recent Developments
7.14 Dr Reddy’s Laboratories
7.14.1 Dr Reddy’s Laboratories Comapny Information
7.14.2 Dr Reddy’s Laboratories Business Overview
7.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
7.14.5 Dr Reddy’s Laboratories Recent Developments
7.15 Bayer
7.15.1 Bayer Comapny Information
7.15.2 Bayer Business Overview
7.15.3 Bayer Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Bayer Transdermal Patch Product Portfolio
7.15.5 Bayer Recent Developments
7.16 Mundipharma
7.16.1 Mundipharma Comapny Information
7.16.2 Mundipharma Business Overview
7.16.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Mundipharma Transdermal Patch Product Portfolio
7.16.5 Mundipharma Recent Developments
7.17 Endo International
7.17.1 Endo International Comapny Information
7.17.2 Endo International Business Overview
7.17.3 Endo International Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Endo International Transdermal Patch Product Portfolio
7.17.5 Endo International Recent Developments
7.18 Beijing Tide Pharmaceutical
7.18.1 Beijing Tide Pharmaceutical Comapny Information
7.18.2 Beijing Tide Pharmaceutical Business Overview
7.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
7.18.5 Beijing Tide Pharmaceutical Recent Developments
8 NORTH AMERICA
8.1 North America Transdermal Patch Market Size by Type
8.1.1 North America Transdermal Patch Revenue by Type (2019-2030)
8.1.2 North America Transdermal Patch Sales by Type (2019-2030)
8.1.3 North America Transdermal Patch Price by Type (2019-2030)
8.2 North America Transdermal Patch Market Size by Application
8.2.1 North America Transdermal Patch Revenue by Application (2019-2030)
8.2.2 North America Transdermal Patch Sales by Application (2019-2030)
8.2.3 North America Transdermal Patch Price by Application (2019-2030)
8.3 North America Transdermal Patch Market Size by Country
8.3.1 North America Transdermal Patch Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Transdermal Patch Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Transdermal Patch Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Transdermal Patch Market Size by Type
9.1.1 Europe Transdermal Patch Revenue by Type (2019-2030)
9.1.2 Europe Transdermal Patch Sales by Type (2019-2030)
9.1.3 Europe Transdermal Patch Price by Type (2019-2030)
9.2 Europe Transdermal Patch Market Size by Application
9.2.1 Europe Transdermal Patch Revenue by Application (2019-2030)
9.2.2 Europe Transdermal Patch Sales by Application (2019-2030)
9.2.3 Europe Transdermal Patch Price by Application (2019-2030)
9.3 Europe Transdermal Patch Market Size by Country
9.3.1 Europe Transdermal Patch Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Transdermal Patch Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Transdermal Patch Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Transdermal Patch Market Size by Type
10.1.1 China Transdermal Patch Revenue by Type (2019-2030)
10.1.2 China Transdermal Patch Sales by Type (2019-2030)
10.1.3 China Transdermal Patch Price by Type (2019-2030)
10.2 China Transdermal Patch Market Size by Application
10.2.1 China Transdermal Patch Revenue by Application (2019-2030)
10.2.2 China Transdermal Patch Sales by Application (2019-2030)
10.2.3 China Transdermal Patch Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Transdermal Patch Market Size by Type
11.1.1 Asia Transdermal Patch Revenue by Type (2019-2030)
11.1.2 Asia Transdermal Patch Sales by Type (2019-2030)
11.1.3 Asia Transdermal Patch Price by Type (2019-2030)
11.2 Asia Transdermal Patch Market Size by Application
11.2.1 Asia Transdermal Patch Revenue by Application (2019-2030)
11.2.2 Asia Transdermal Patch Sales by Application (2019-2030)
11.2.3 Asia Transdermal Patch Price by Application (2019-2030)
11.3 Asia Transdermal Patch Market Size by Country
11.3.1 Asia Transdermal Patch Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Transdermal Patch Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Transdermal Patch Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Transdermal Patch Market Size by Type
12.1.1 MEALA Transdermal Patch Revenue by Type (2019-2030)
12.1.2 MEALA Transdermal Patch Sales by Type (2019-2030)
12.1.3 MEALA Transdermal Patch Price by Type (2019-2030)
12.2 MEALA Transdermal Patch Market Size by Application
12.2.1 MEALA Transdermal Patch Revenue by Application (2019-2030)
12.2.2 MEALA Transdermal Patch Sales by Application (2019-2030)
12.2.3 MEALA Transdermal Patch Price by Application (2019-2030)
12.3 MEALA Transdermal Patch Market Size by Country
12.3.1 MEALA Transdermal Patch Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Transdermal Patch Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Transdermal Patch Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Transdermal Patch Value Chain Analysis
13.1.1 Transdermal Patch Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Transdermal Patch Production Mode & Process
13.2 Transdermal Patch Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Transdermal Patch Distributors
13.2.3 Transdermal Patch Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
